FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development
Mar 07 2022 FDA I Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research A rare disease is any disease that...
FDA, CDER's Drug Approvals and Programming to Speed Therapeutic Development
OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings
FDA Regulation, Soaps & Lotions
FDA Regulation, Cosmetics or Drugs?
FDA approves drug for adults with rare form of bone marrow disorder
FDA updates Sotrovimab emergency use authorization
FDA authorizes revisions to Evusheld dosing
FDA Approves Treatment for Wider Range of Patients with Heart Failure
FDA, At-Home OTC COVID-19 Diagnostic Tests
FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States
FDA Regulation, Development & Approval Process | Drugs
FDA Regulation, hand sanitizer
FDA Regulation, Medical Device Classification
FDA, New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant
What Is the Approval Process for Generic Drugs?
Medical Device, FDA Regulations required for export to the US
FDA Regulations : Cosmetics Labeling
FDA Approves First Generic of Restasis
FDA, Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age
FDA Takes Key Action by Approving Second COVID-19 Vaccine